1. Academic Validation
  2. Synthesis and Evaluation of the 2-Aminothiazoles as Anti-Tubercular Agents

Synthesis and Evaluation of the 2-Aminothiazoles as Anti-Tubercular Agents

  • PLoS One. 2016 May 12;11(5):e0155209. doi: 10.1371/journal.pone.0155209.
Edward A Kesicki 1 Mai A Bailey 1 Yulia Ovechkina 1 Julie V Early 1 Torey Alling 1 Julie Bowman 1 Edison S Zuniga 1 Suryakanta Dalai 2 Naresh Kumar 2 Thierry Masquelin 3 Philip A Hipskind 3 Joshua O Odingo 1 Tanya Parish 1
Affiliations

Affiliations

  • 1 TB Discovery Research, Infectious Disease Research Institute, Seattle, Washington, United States of America.
  • 2 Jubilant Chemsys Limited, B-34, Sector 58, Noida, India.
  • 3 Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana, United States of America.
Abstract

The 2-aminothiazole series has anti-bacterial activity against the important global pathogen Mycobacterium tuberculosis. We explored the nature of the activity by designing and synthesizing a large number of analogs and testing these for activity against M. tuberculosis, as well as eukaryotic cells. We determined that the C-2 position of the thiazole can accommodate a range of lipophilic substitutions, while both the C-4 position and the thiazole core are sensitive to change. The series has good activity against M. tuberculosis growth with sub-micromolar minimum inhibitory concentrations being achieved. A representative analog was selective for mycobacterial species over other bacteria and was rapidly bactericidal against replicating M. tuberculosis. The mode of action does not appear to involve iron chelation. We conclude that this series has potential for further development as novel anti-tubercular agents.

Figures
Products